The dexamethasone suppression test in panic disorder and agoraphobia

G. C. Curtis, O. G. Cameron, R. M. Nesse

Research output: Contribution to journalArticlepeer-review

92 Scopus citations

Abstract

Reports that imipramine and phenelzine prevent panic attacks in agoraphobia suggest the possibility that agoraphobia and/or panic disorder might be a clinical manifestation of underlying depression. To test this hypothesis, dexamethasone suppression tests (DSTs) were performed in 10 patients meeting DSM-III criteria for agoraphobia with panic attacks, 6 for panic disorder, and 4 whose diagnosis could have been either panic disorder or agoraphobia except that another axis I disorder precluded such a diagnosis. Abnormal DSTs were observed in only 3 patients and appeared to be attributable to causes other than panic attacks or agoraphobia. The results suggest that panic attacks and endogenous depression are separate disorders and that the anti-panic properties of imipramine and phenelzine are separate from their antidepressant actions.

Original languageEnglish (US)
Pages (from-to)1043-1046
Number of pages4
JournalAmerican Journal of Psychiatry
Volume139
Issue number8
DOIs
StatePublished - Jan 1 1982
Externally publishedYes

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'The dexamethasone suppression test in panic disorder and agoraphobia'. Together they form a unique fingerprint.

Cite this